Get started
Author

Francesca Elice

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study
2005 · R. Cairoli, Alessandro Beghini, et al. · Blood · 382
PDF
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
2011 · Antonio Palumbo, Michele Cavo, et al. · Journal of Clinical Oncology · 327
PDF
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma
2005 · Maurizio Zangari, Dixie Esseltine, et al. · British Journal of Haematology · 200
PDF
Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents
2009 · Maurizio Zangari, Louis M. Fink, et al. · Journal of Clinical Oncology · 196
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
2004 · Alessandro Beghini, Carla B Ripamonti, et al. · PubMed · 163
PDF
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism
2006 · Francesca Elice, Louis Fink, et al. · British Journal of Haematology · 135
Side effects of anti-angiogenic drugs
2012 · Francesca Elice, Francesco Rodeghiero · Thrombosis Research · 133
Thrombosis associated with angiogenesis inhibitors
2009 · Francesca Elice, Francesco Rodeghiero, et al. · Best Practice & Research Clinical Haematology · 119
Hemostatic Dysfunction in Paraproteinemias and Amyloidosis
2007 · Maurizio Zangari, Francesca Elice, et al. · Seminars in Thrombosis and Hemostasis · 76
Thrombosis in multiple myeloma
2007 · Maurizio Zangari, Francesca Elice, et al. · Expert Review of Anticancer Therapy · 68
Hemostatic complications of angiogenesis inhibitors in cancer patients
2008 · Francesca Elice, Jack Jacoub, et al. · American Journal of Hematology · 65
Prolonged overall survival with second on-demand autologous transplant in multiple myeloma
2006 · Francesca Elice, Roberto Raimondi, et al. · American Journal of Hematology · 62
PDF
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
2020 · Paola Tacchetti, Lucia Pantani, et al. · The Lancet Haematology · 57
Bortezomib‐ and thalidomide‐induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study
2014 · Paola Tacchetti, Carolina Terragna, et al. · American Journal of Hematology · 57
Thalidomide and Thrombosis
2003 · Francesco Rodeghiero, Francesca Elice · Pathophysiology of Haemostasis and Thrombosis · 53
PDF
Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.
2005 · Maurizio Zangari, Bart Barlogie, et al. · Blood · 51
Hematologic malignancies and thrombosis
2011 · F. Elice, F. Rodeghiero · Thrombosis Research · 49
Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact
2010 · F. Elice, F. Rodeghiero · Thrombosis Research · 46
Predictive value of alkaline phosphatase for response and time to progression in bortezomib‐treated multiple myeloma patients
2007 · Maurizio Zangari, Dixie Esseltine, et al. · American Journal of Hematology · 33
PDF
Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients
2010 · Sara Bringhen, Alessandra Larocca, et al. · Blood · 29
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
2004 · Monica Galli, Francesca Elice, et al. · PubMed · 29
A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.
2009 · Antonio Palumbo, Michele Cavo, et al. · Blood · 21
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)
2021 · Domenico Russo, Nicola Polverelli, et al. · Bone Marrow Transplantation · 20
Immunomodulatory drugs in multiple myeloma
2005 · Maurizio Zangari, Francesca Elice, et al. · Expert Opinion on Investigational Drugs · 20
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia
2021 · Rachele Ciccocioppo, Davide Gibellini, et al. · Stem Cell Research & Therapy · 17
PDF
Works count: 64
Citation count: 2,514
H-index: 21
I10-index: 28
Year
Topic
Type